Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 172

1.

Polycomb dysregulation in gliomagenesis targets a Zfp423-dependent differentiation network.

Signaroldi E, Laise P, Cristofanon S, Brancaccio A, Reisoli E, Atashpaz S, Terreni MR, Doglioni C, Pruneri G, Malatesta P, Testa G.

Nat Commun. 2016 Feb 29;7:10753. doi: 10.1038/ncomms10753.

2.

Internal (His)6-tagging delivers a fully functional hetero-oligomeric class II chaperonin in high yield.

Paul DM, Beuron F, Sessions RB, Brancaccio A, Bigotti MG.

Sci Rep. 2016 Feb 9;6:20696. doi: 10.1038/srep20696.

3.

Quantification, 2DE analysis and identification of enriched glycosylated proteins from mouse muscles: Difficulties and alternatives.

de Fátima MenegociEugênio P, Assunção NA, Sciandra F, Aquino A, Brancaccio A, Carrilho E.

Electrophoresis. 2016 Jan;37(2):321-34. doi: 10.1002/elps.201500362. Epub 2015 Dec 15.

PMID:
26542084
4.

Genetic Engineering of Dystroglycan in Animal Models of Muscular Dystrophy.

Sciandra F, Bigotti MG, Giardina B, Bozzi M, Brancaccio A.

Biomed Res Int. 2015;2015:635792. doi: 10.1155/2015/635792. Epub 2015 Aug 24. Review.

5.

The evolution of the dystroglycan complex, a major mediator of muscle integrity.

Adams JC, Brancaccio A.

Biol Open. 2015 Aug 28;4(9):1163-79. doi: 10.1242/bio.012468.

6.

Proteasome Activity Is Affected by Fluctuations in Insulin-Degrading Enzyme Distribution.

Sbardella D, Tundo GR, Sciandra F, Bozzi M, Gioia M, Ciaccio C, Tarantino U, Brancaccio A, Coletta M, Marini S.

PLoS One. 2015 Jul 17;10(7):e0132455. doi: 10.1371/journal.pone.0132455. eCollection 2015.

7.

Fault detection in dielectric grid scatterers.

Brancaccio A, Solimene R.

Opt Express. 2015 Apr 6;23(7):8200-15. doi: 10.1364/OE.23.008200.

PMID:
25968659
8.

The Structure of the T190M Mutant of Murine α-Dystroglycan at High Resolution: Insight into the Molecular Basis of a Primary Dystroglycanopathy.

Bozzi M, Cassetta A, Covaceuszach S, Bigotti MG, Bannister S, Hübner W, Sciandra F, Lamba D, Brancaccio A.

PLoS One. 2015 May 1;10(5):e0124277. doi: 10.1371/journal.pone.0124277. eCollection 2015.

9.

Chromatin signaling in muscle stem cells: interpreting the regenerative microenvironment.

Brancaccio A, Palacios D.

Front Aging Neurosci. 2015 Apr 7;7:36. doi: 10.3389/fnagi.2015.00036. eCollection 2015. Review.

10.

Role of gelatinases in pathological and physiological processes involving the dystrophin-glycoprotein complex.

Bozzi M, Sciandra F, Brancaccio A.

Matrix Biol. 2015 May-Jul;44-46:130-7. doi: 10.1016/j.matbio.2015.02.005. Epub 2015 Feb 17. Review.

11.

α-dystroglycan is a potential target of matrix metalloproteinase MMP-2.

Sbardella D, Sciandra F, Gioia M, Marini S, Gori A, Giardina B, Tarantino U, Coletta M, Brancaccio A, Bozzi M.

Matrix Biol. 2015 Jan;41:2-7. doi: 10.1016/j.matbio.2014.11.007. Epub 2014 Dec 4.

PMID:
25483986
12.

A new monoclonal antibody DAG-6F4 against human alpha-dystroglycan reveals reduced core protein in some, but not all, dystroglycanopathy patients.

Humphrey EL, Lacey E, Le LT, Feng L, Sciandra F, Morris CR, Hewitt JE, Holt I, Brancaccio A, Barresi R, Sewry CA, Brown SC, Morris GE.

Neuromuscul Disord. 2015 Jan;25(1):32-42. doi: 10.1016/j.nmd.2014.09.005. Epub 2014 Sep 16.

PMID:
25387694
13.

Impact of a phenytoin loading dose program in the emergency department.

Brancaccio A, Giuliano C, McNorton K, Delgado G Jr.

Am J Health Syst Pharm. 2014 Nov 1;71(21):1862-9. doi: 10.2146/ajhp140039.

PMID:
25320136
14.

Insights from molecular dynamics simulations: structural basis for the V567D mutation-induced instability of zebrafish alpha-dystroglycan and comparison with the murine model.

Pirolli D, Sciandra F, Bozzi M, Giardina B, Brancaccio A, De Rosa MC.

PLoS One. 2014 Jul 31;9(7):e103866. doi: 10.1371/journal.pone.0103866. eCollection 2014.

15.

The multiple affinities of α-dystroglycan.

Sciandra F, Bozzi M, Bigotti MG, Brancaccio A.

Curr Protein Pept Sci. 2013 Nov;14(7):626-34. Review.

PMID:
24206164
16.

Increased levels of expression of dystroglycan may protect the heart.

Brancaccio A.

Neuromuscul Disord. 2013 Nov;23(11):867-70. doi: 10.1016/j.nmd.2013.06.371. Epub 2013 Jul 30.

PMID:
23911074
17.

Probing the stability of the "naked" mucin-like domain of human α-dystroglycan.

Bozzi M, Di Stasio E, Scaglione GL, Desiderio C, Martelli C, Giardina B, Sciandra F, Brancaccio A.

BMC Biochem. 2013 Jul 1;14:15. doi: 10.1186/1471-2091-14-15.

18.

Enzymatic processing by MMP-2 and MMP-9 of wild-type and mutated mouse β-dystroglycan.

Sbardella D, Inzitari R, Iavarone F, Gioia M, Marini S, Sciandra F, Castagnola M, Van den Steen PE, Opdenakker G, Giardina B, Brancaccio A, Coletta M, Bozzi M.

IUBMB Life. 2012 Dec;64(12):988-94. doi: 10.1002/iub.1095. Epub 2012 Nov 5.

19.

Insertion of a myc-tag within α-dystroglycan domains improves its biochemical and microscopic detection.

Morlacchi S, Sciandra F, Bigotti MG, Bozzi M, Hübner W, Galtieri A, Giardina B, Brancaccio A.

BMC Biochem. 2012 Jul 26;13:14. doi: 10.1186/1471-2091-13-14.

20.

Dystroglycan is associated to the disulfide isomerase ERp57.

Sciandra F, Angelucci E, Altieri F, Ricci D, Hübner W, Petrucci TC, Giardina B, Brancaccio A, Bozzi M.

Exp Cell Res. 2012 Nov 15;318(19):2460-9. doi: 10.1016/j.yexcr.2012.07.006. Epub 2012 Jul 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk